Search This Blog

References for MyAspergersChild.com


1.      Allen D, Evans C, Hider A, Hawkins S, Peckett H, Morgan H (2008). "Offending behaviour in adults with Asperger syndrome". J Autism Dev Disord 38 (4): 748–58. doi:10.1007/s10803-007-0442-9. PMID 17805955.
2.      American Psychiatric Association (2000). "Diagnostic criteria for 299.80 Asperger's Disorder (AD)". Diagnostic and Statistical Manual of Mental Disorders (4th, text revision (DSM-IV-TR) ed.). ISBN 0-89042-025-4.
3.      Arndt TL, Stodgell CJ, Rodier PM (2005). "The teratology of autism". Int J Dev Neurosci 23 (2–3): 189–99. doi:10.1016/j.ijdevneu.2004.11.001. PMID 15749245.
4.      Asperger H; tr. and annot. Frith U (1991) [1944]. "'Autistic psychopathy' in childhood". in Frith U. Autism and Asperger syndrome. Cambridge University Press. pp. 37–92. ISBN 0-521-38608-X.
6.      Auyeung B, Baron-Cohen S, Wheelwright S, Allison C (2008). "The Autism Spectrum Quotient: Children's Version (AQ-Child)" (PDF). J Autism Dev Disord 38 (7): 1230–40. doi:10.1007/s10803-007-0504-z. PMID 18064550. http://autismresearchcenter.com/docs/papers/2008_Auyeung_etal_ChildAQ.pdf. Retrieved on 2009-01-02.
7.      Baron-Cohen S (2002). "Is Asperger syndrome necessarily viewed as a disability?". Focus Autism Other Dev Disabl 17 (3): 186–91. doi:10.1177/10883576020170030801. A preliminary, freely readable draft is in: Baron-Cohen S (2002). "Is Asperger's syndrome necessarily a disability?" (PDF). Cambridge: Autism Research Centre. http://autismresearchcentre.com/docs/papers/2002_BC_ASDisability.pdf. Retrieved on 2008-12-02.
9.      Baron-Cohen S (2008). "The evolution of brain mechanisms for social behavior". in Crawford C, Krebs D (eds.). Foundations of Evolutionary Psychology. Lawrence Erlbaum. pp. 415–32. ISBN 0‑8058‑5957‑8.
10.  Baron-Cohen S, Hoekstra RA, Knickmeyer R, Wheelwright S (2006). "The Autism-Spectrum Quotient (AQ)—adolescent version" (PDF). J Autism Dev Disord 36 (3): 343–50. doi:10.1007/s10803-006-0073-6. PMID 16552625. http://autismresearchcenter.com/docs/papers/2006_BC_Hoekstra_etal_AQ-adol.pdf. Retrieved on 2009-01-02.
12.  Baron-Cohen S, Leslie AM, Frith U (1985). "Does the autistic child have a 'theory of mind'?" (PDF). Cognition 21 (1): 37–46. doi:10.1016/0010-0277(85)90022-8. PMID 2934210. http://ruccs.rutgers.edu/~aleslie/Baron-Cohen%20Leslie%20&%20Frith%201985.pdf. Retrieved on 2007-06-28.
13.  Baskin JH, Sperber M, Price BH (2006). "Asperger syndrome revisited". Rev Neurol Dis 3 (1): 1–7. PMID 16596080.
14.  Berthier ML, Starkstein SE, Leiguarda R (1990). "Developmental cortical anomalies in Asperger's syndrome: neuroradiological findings in two patients". J Neuropsychiatry Clin Neurosci 2 (2): 197–201. PMID 2136076.
15.  Blacher J, Kraemer B, Schalow M (2003). "Asperger syndrome and high functioning autism: research concerns and emerging foci". Curr Opin Psychiatry 16 (5): 535–542. doi:10.1097/00001504-200309000-00008.
16.  Bogdashina O (2003). Sensory Perceptional Issues in Autism and Asperger Syndrome: Different Sensory Experiences, Different Perceptual Worlds. Jessica Kingsley. ISBN 1-843101-66-1.
17.  Campbell JM (2005). "Diagnostic assessment of Asperger's disorder: a review of five third-party rating scales". J Autism Dev Disord 35 (1): 25–35. doi:10.1007/s10803-004-1028-4. PMID 15796119.
18.  Cederlund M, Gillberg C (2004). "One hundred males with Asperger syndrome: a clinical study of background and associated factors". Dev Med Child Neurol 46 (10): 652–60. doi:10.1017/S0012162204001100. PMID 15473168.
19.  Chavez B, Chavez-Brown M, Sopko MA, Rey JA (2007). "Atypical antipsychotics in children with pervasive developmental disorders". Pediatr Drugs 9 (4): 249–66. doi:10.2165/00148581-200709040-00006. PMID 17705564.
21.  Clarke J, van Amerom G (2007). "'Surplus suffering': differences between organizational understandings of Asperger's syndrome and those people who claim the 'disorder'". Disabil Soc 22 (7): 761–76. doi:10.1080/09687590701659618.
22.  Clarke J, van Amerom G (2008). "Asperger's syndrome: differences between parents' understanding and those diagnosed". Soc Work Health Care 46 (3): 85–106. doi:10.1300/J010v46n03_05. PMID 18551831.
24.  Dakin CJ (2005). "Life on the outside: A personal perspective of Asperger syndrome". in Stoddart KP. Children, Youth and Adults with Asperger Syndrome: Integrating Multiple Perspectives. Jessica Kingsley. pp. 352–61. ISBN 1-84310-319-2.
25.  Ehlers S, Gillberg C (1993). "The epidemiology of Asperger's syndrome. A total population study". J Child Psychol Psychiat 34 (8): 1327–50. doi:10.1111/j.1469-7610.1993.tb02094.x. PMID 8294522.
26.  Epstein T, Saltzman-Benaiah J, O'Hare A, Goll JC, Tuck S (2008). "Associated features of Asperger Syndrome and their relationship to parenting stress". Child Care Health Dev 34 (4): 503–11. doi:10.1111/j.1365-2214.2008.00834.x. PMID 19154552.
28.   Fitzgerald M, Bellgrove MA (2006). "The overlap between alexithymia and Asperger's syndrome". J Autism Dev Disord 36 (4): 573–6. doi:10.1007/s10803-006-0096-z. PMID 16755385.
29.  Fitzgerald M, Corvin A (2001). "Diagnosis and differential diagnosis of Asperger syndrome". Adv Psychiatric Treat 7 (4): 310–8. doi:10.1192/apt.7.4.310. http://apt.rcpsych.org/cgi/content/full/7/4/310.
30.  Fombonne E (2007). "Epidemiological surveys of pervasive developmental disorders". in Volkmar FR. Autism and Pervasive Developmental Disorders (2nd ed.). Cambridge University Press. pp. 33–68. ISBN 0-521-54957-4.
32.  Foster B, King BH (2003). "Asperger syndrome: to be or not to be?". Curr Opin Pediatr 15 (5): 491–4. doi:10.1097/00008480-200310000-00008. PMID 14508298.
33.  Frith U (2004). "Emanuel Miller lecture: confusions and controversies about Asperger syndrome". J Child Psychol Psychiatry 45 (4): 672–86. doi:10.1111/j.1469-7610.2004.00262.x. PMID 15056300.
34.  Ghaziuddin M, Weidmer-Mikhail E, Ghaziuddin N (1998). "Comorbidity of Asperger syndrome: a preliminary report". J Intellect Disabil Res 42 (4): 279–83. PMID 9786442.
35.  Gillberg C (2008). "Asperger syndrome—mortality and morbidity". in Rausch JL, Johnson ME, Casanova MF (eds.). Asperger's Disorder. Informa Healthcare. pp. 63–80. ISBN 0-8493-8360-9.
36.  Gillberg C, Billstedt E (2000). "Autism and Asperger syndrome: coexistence with other clinical disorders". Acta Psychiatr Scand 102 (5): 321–30. doi:10.1034/j.1600-0447.2000.102005321.x. PMID 11098802.
37.  Gillberg IC, Gillberg C (1989). "Asperger syndrome—some epidemiological considerations: a research note". J Child Psychol Psychiatry 30 (4): 631–8. doi:10.1111/j.1469-7610.1989.tb00275.x. PMID 2670981.
38.  Gowen E, Miall RC (2005). "Behavioural aspects of cerebellar function in adults with Asperger syndrome". Cerebellum 4 (4): 279–89. doi:10.1080/14734220500355332. PMID 16321884.
39.  Happé F, Frith U (2006). "The weak coherence account: detail-focused cognitive style in autism spectrum disorders". J Autism Dev Disord 36 (1): 5–25. doi:10.1007/s10803-005-0039-0. PMID 16450045.
40.  Happé F, Ronald A, Plomin R (2006). "Time to give up on a single explanation for autism". Nat Neurosci 9 (10): 1218–20. doi:10.1038/nn1770. PMID 17001340.
41.  Herera S (2005-02-25). "Mild autism has 'selective advantages'". CNBC. http://www.msnbc.msn.com/id/7030731/. Retrieved on 2007-11-14.
42.  Hill E, Berthoz S (2006). "Response". J Autism Dev Disord 36 (8): 1143–5. doi:10.1007/s10803-006-0287-7. PMID 17080269.
43.  Iacoboni M, Dapretto M (2006). "The mirror neuron system and the consequences of its dysfunction". Nat Rev Neurosci 7 (12): 942–51. doi:10.1038/nrn2024. PMID 17115076.
45.  Kasari C, Rotheram-Fuller E (2005). "Current trends in psychological research on children with high-functioning autism and Asperger disorder". Curr Opin Psychiatry 18 (5): 497–501. doi:10.1097/01.yco.0000179486.47144.61. PMID 16639107.
46.  Khouzam HR, El-Gabalawi F, Pirwani N, Priest F (2004). "Asperger's disorder: a review of its diagnosis and treatment". Compr Psychiatry 45 (3): 184–91. doi:10.1016/j.comppsych.2004.02.004. PMID 15124148.
51.  Lord C, Cook EH, Leventhal BL, Amaral DG (2000). "Autism spectrum disorders". Neuron 28 (2): 355–63. doi:10.1016/S0896-6273(00)00115-X. PMID 11144346.
52.  Lyons V, Fitzgerald M (2004). "Humor in autism and Asperger syndrome". J Autism Dev Disord 34 (5): 521–31. doi:10.1007/s10803-004-2547-8. PMID 15628606.
53.  Matson JL (2007). "Determining treatment outcome in early intervention programs for autism spectrum disorders: a critical analysis of measurement issues in learning based interventions". Res Dev Disabil 28 (2): 207–18. doi:10.1016/j.ridd.2005.07.006. PMID 16682171.
54.  Mattila ML, Kielinen M, Jussila K et al. (2007). "An epidemiological and diagnostic study of Asperger syndrome according to four sets of diagnostic criteria". J Am Acad Child Adolesc Psychiatry 46 (5): 636–46. doi:10.1097/chi.0b013e318033ff42. PMID 17450055.
55.  McPartland J, Klin A (2006). "Asperger's syndrome". Adolesc Med Clin 17 (3): 771–88. doi:10.1016/j.admecli.2006.06.010 (inactive 2008-06-25). PMID 17030291.
56.  Molloy H, Vasil L (2002). "The social construction of Asperger Syndrome: the pathologising of difference?". Disabil Soc 17 (6): 659–69. doi:10.1080/0968759022000010434.
58.  Mottron L, Dawson M, Soulières I, Hubert B, Burack J (2006). "Enhanced perceptual functioning in autism: an update, and eight principles of autistic perception". J Autism Dev Disord 36 (1): 27–43. doi:10.1007/s10803-005-0040-7. PMID 16453071.
59.  Müller RA (2007). "The study of autism as a distributed disorder". Ment Retard Dev Disabil Res Rev 13 (1): 85–95. doi:10.1002/mrdd.20141. PMID 17326118.
60.  Murphy DG, Daly E, Schmitz N et al. (2006). "Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study". Am J Psychiatry 163 (5): 934–6. doi:10.1176/appi.ajp.163.5.934. PMID 16648340.
62.  National Institute of Neurological Disorders and Stroke (NINDS) (2007-07-31). "Asperger syndrome fact sheet". http://www.ninds.nih.gov/disorders/asperger/detail_asperger.htm. Retrieved on 2007-08-24. NIH Publication No. 05-5624.
63.  Newcomer JW (2007). "Antipsychotic medications: metabolic and cardiovascular risk". J Clin Psychiatry 68 (suppl 4): 8–13. PMID 17539694.
64.  Newman SS, Ghaziuddin M (2008). "Violent crime in Asperger syndrome: the role of psychiatric comorbidity". J Autism Dev Disord 38 (10): 1848–52. doi:10.1007/s10803-008-0580-8. PMID 18449633.
65.  Nishitani N, Avikainen S, Hari R (2004). "Abnormal imitation-related cortical activation sequences in Asperger's syndrome". Ann Neurol 55 (4): 558–62. doi:10.1002/ana.20031. PMID 15048895.
67.  Piven J, Palmer P, Jacobi D, Childress D, Arndt S (1997). "Broader autism phenotype: evidence from a family history study of multiple-incidence autism families" (PDF). Am J Psychiatry 154 (2): 185–90. PMID 9016266. http://ajp.psychiatryonline.org/cgi/reprint/154/2/185.pdf.
68.  Polimeni MA, Richdale AL, Francis AJ (2005). "A survey of sleep problems in autism, Asperger's disorder and typically developing children". J Intellect Disabil Res 49 (4): 260–8. doi:10.1111/j.1365-2788.2005.00642.x. PMID 15816813.
69.  Prior M, Ozonoff S (2007). "Psychological factors in autism". in Volkmar FR. Autism and Pervasive Developmental Disorders (2nd ed.). Cambridge University Press. pp. 69–128. ISBN 0-521-54957-4.
71.  Rao PA, Beidel DC, Murray MJ (2008). "Social skills interventions for children with Asperger's syndrome or high-functioning autism: a review and recommendations". J Autism Dev Disord 38 (2): 353–61. doi:10.1007/s10803-007-0402-4. PMID 17641962.
72.  Rapin I (2001). "Autism spectrum disorders: relevance to Tourette syndrome". Adv Neurol 85: 89–101. PMID 11530449.
73.  Rinehart NJ, Bradshaw JL, Brereton AV, Tonge BJ (2002). "A clinical and neurobehavioural review of high-functioning autism and Asperger's disorder". Aust N Z J Psychiatry 36 (6): 762–70. doi:10.1046/j.1440-1614.2002.01097.x. PMID 12406118.
74.  Rogers SJ, Ozonoff S (2005). "Annotation: what do we know about sensory dysfunction in autism? A critical review of the empirical evidence". J Child Psychol Psychiatry 46 (12): 1255–68. doi:10.1111/j.1469-7610.2005.01431.x. PMID 16313426.
75.  Rutter M (2005). "Incidence of autism spectrum disorders: changes over time and their meaning". Acta Paediatr 94 (1): 2–15. doi:10.1080/08035250410023124. PMID 15858952.
76.  Shattuck PT, Grosse SD (2007). "Issues related to the diagnosis and treatment of autism spectrum disorders". Ment Retard Dev Disabil Res Rev 13 (2): 129–35. doi:10.1002/mrdd.20143. PMID 17563895.
77.  Sofronoff K, Leslie A, Brown W (2004). "Parent management training and Asperger syndrome: a randomized controlled trial to evaluate a parent based intervention". Autism 8 (3): 301–17. doi:10.1177/1362361304045215. PMID 15358872.
78.  South M, Ozonoff S, McMahon WM (2005). "Repetitive behavior profiles in Asperger syndrome and high-functioning autism". J Autism Dev Disord 35 (2): 145–58. doi:10.1007/s10803-004-1992-8. PMID 15909401.
79.  Stachnik JM, Nunn-Thompson C (2007). "Use of atypical antipsychotics in the treatment of autistic disorder". Ann Pharmacother 41 (4): 626–34. doi:10.1345/aph.1H527. PMID 17389666.
80.  Staller J (2006). "The effect of long-term antipsychotic treatment on prolactin". J Child Adolesc Psychopharmacol 16 (3): 317–26. doi:10.1089/cap.2006.16.317. PMID 16768639.
82.  Szatmari P, Bremner R, Nagy J (1989). "Asperger's syndrome: a review of clinical features". Can J Psychiatry 34 (6): 554–60. PMID 2766209.
83.  Tani P, Lindberg N, Joukamaa M et al. (2004). "Asperger syndrome, alexithymia and perception of sleep". Neuropsychobiology 49 (2): 64–70. doi:10.1159/000076412. PMID 14981336.
85.  Toth K, King BH (2008). "Asperger's syndrome: diagnosis and treatment". Am J Psychiatry 165 (8): 958–63. doi:10.1176/appi.ajp.2008.08020272. PMID 18676600.
88.  Willey LH (1999). Pretending to be Normal: Living with Asperger's Syndrome. Jessica Kingsley. ISBN 1-85302-749-9.
89.  Williams CC (2005). "In search of an Asperger". in Stoddart KP. Children, Youth and Adults with Asperger Syndrome: Integrating Multiple Perspectives. Jessica Kingsley. pp. 242–52. ISBN 1-84310-319-2. "The life prospects of people with AS would change if we shifted from viewing AS as a set of dysfunctions, to viewing it as a set of differences that have merit."
90.  Wing L (1981). "Asperger's syndrome: a clinical account". Psychol Med 11 (1): 115–29. PMID 7208735. http://www.mugsy.org/wing2.htm. Retrieved on 2007-08-15.
91.  Wing L (1991). "The relationship between Asperger's syndrome and Kanner's autism". in Frith U. Autism and Asperger syndrome. Cambridge University Press. pp. 93–121. ISBN 0-521-38608-X.
92.  Witwer AN, Lecavalier L (2008). "Examining the validity of autism spectrum disorder subtypes". J Autism Dev Disord 38 (9): 1611–24. doi:10.1007/s10803-008-0541-2. PMID 18327636.
94.  Woodbury-Smith MR, Volkmar FR (2008). "Asperger syndrome". Eur Child Adolesc Psychiatry 18: 2. doi:10.1007/s00787-008-0701-0. PMID 18563474.
95.  World Health Organization (2006). "F84. Pervasive developmental disorders". International Statistical Classification of Diseases and Related Health Problems (10th (ICD-10) ed.).

Medications for Asperger's and High-Functioning Autism

“Are there any medications used to treat the symptoms of Asperger’s Syndrome or High Functioning Autism?”

No medications directly treat the core symptoms of Asperger’s or High Functioning Autism. Although research into the effectiveness of pharmaceutical intervention for Asperger’s is limited, it is essential to diagnose and treat “comorbid” (i.e., related) conditions.

Deficits in self-identifying emotions or in observing effects of one's behavior on others can make it difficult for kids with Asperger’s to see why medication may be appropriate. Medication can be effective in combination with behavioral interventions and environmental accommodations in treating comorbid symptoms (e.g., anxiety disorder, major depressive disorder, inattention, aggression, etc.).

Risperidone and olanzapine have been shown to reduce the associated symptoms of Asperger’s. Risperidone can reduce repetitive and self-injurious behaviors, aggressive outbursts and impulsivity, and improve stereotypical patterns of behavior and social relatedness. The selective serotonin reuptake inhibitors (SSRIs) fluoxetine, fluvoxamine and sertraline have been effective in treating restricted and repetitive interests and behaviors.

Care must be taken with medications:
  • Weight gain and fatigue are commonly reported side effects of risperidone, which may also lead to increased risk for extrapyramidal symptoms (e.g., restlessness and dystonia) and increased serum prolactin levels.
  • SSRIs can lead to manifestations of behavioral activation (e.g., increased impulsivity, aggression and sleep disturbance).
  • Sedative side-effects in school-age kids have ramifications for classroom learning. 
  • Sedation and weight gain are more common with olanzapine, which has also been linked with diabetes.
  • Abnormalities in metabolism, cardiac conduction times, and an increased risk of type 2 diabetes have been raised as concerns with these medications, along with serious long-term neurological side effects.

Note: Kids with Asperger’s and High-Functioning Autism may be unable to identify and communicate their internal moods and emotions or to tolerate side effects that, for most individuals, would not be a problem.

More resources for parents of children and teens with High-Functioning Autism and Asperger's:

==> How To Prevent Meltdowns and Tantrums In Children With High-Functioning Autism and Asperger's

==> Parenting System that Significantly Reduces Defiant Behavior in Teens with Aspergers and High-Functioning Autism

==> Launching Adult Children with Asperger's and High-Functioning Autism: Guide for Parents Who Want to Promote Self-Reliance

==> Teaching Social Skills and Emotion Management to Children and Teens with Asperger's and High-Functioning Autism

==> Parenting Children and Teens with High-Functioning Autism: Comprehensive Handbook

==> Unraveling The Mystery Behind Asperger's and High-Functioning Autism: Audio Book


COMMENTS:

Anonymous said...We use efaflex on our son which is an omega 3,6 and 9 and contains evening primrose oil, it has curved his outbursts but we do notice during growth spurts that his moods go out the window and we tried omega without evening primrose in it and it wasn't as effective, so we believe that some of his behavior is brought on by hormones during growth, but peadritician doesn't believe so. The year that he was really bad he grew 13cm in height in that year.

Anonymous said...We have seen amazing changes in my 11 year old aspie will Abilifiy as well.

Anonymous said...Thank you for posting this. I was going to do a internet search to see if there were any meds that we could try for my son.

Anonymous said...My son is on intuniv. He can't have stimulants because of his facial tics and we have really been pleased with the results that intuniv have given him.

Anonymous said...My son is 14 and has Aspergers. We have yet to find a medication to curb his meltdowns!!

Anonymous said...my 11 year old has been on meds for 3 years now and would not be able to function without them. Abilify and Concerta have been the most effective with a recent addition of Kapvay. Abilify has been consistently the most necessary to curb his anxiety. He also struggles with rigid thinking, impulse control and violent outbursts. Still, though, Asperger's is kicking MY ass today! It's definitely a marathon.

Anonymous said...I have a daughter entering her teen years and it has been HELL since school started this year. Doc prescribed risperdal. However, after reading some of the awful side effects, decided not to give it to her. Hormones definitely magnify the outbursts and I disagree with any Doc who says otherwise.

Anonymous said...Focalin XR can help treat the add part and overall helps with the Aspergers

Anonymous said...Abilify has really helped with my son.

Anonymous said... another drug in the same family as risperdol but another generation along and therefore supposedly w/ fewer side effects is Abilify. It hasn't ended my kid's impulsiveness but it's mitigated it and bolstered his mood, which sensory issues and struggles in schools were just hammering. The decision to medicate is a hard one; but I don't want my kid's brain to learn how to be depressed -- once that track is laid down, you zip along it way too easily throughout life.

The Best Therapy for High-Functioning Autism

“What would be the best therapeutic approach for a 6-year-old boy with High-Functioning Autism?”

Click here for the answer...



Aspergers Screening

“When and how do you test a child for Asperger’s Syndrome?”

Moms and dads of kids with Asperger’s (AS) can typically trace differences in their kid's development to as early as 30 months of age. Developmental screening during a routine check-up by a doctor may identify signs that warrant further investigation. The diagnosis of AS is complicated by the use of several different screening instruments, including:
  • Asperger Syndrome Diagnostic Scale (ASDS)
  • Autism Spectrum Quotient (AQ; with versions for kids, teens and grown-ups)
  • Autism Spectrum Screening Questionnaire (ASSQ) 
  • Childhood Asperger Syndrome Test (CAST)
  • Gilliam Asperger's Disorder Scale (GADS) 
  • Krug Asperger's Disorder Index (KADI)

Unfortunately, none have been shown to reliably differentiate between AS and other Autism Spectrum Disorders.

Aspergers: Speech and Language

"Do children with Asperger’s have speech or language problems, or is this purely an issue in Autism?"
 
==> Click here for the answer... 

2024 Statistics of Autism in Chinese Children

Autism Spectrum Disorder (ASD) has emerged as a significant public health concern worldwide, and China is no exception. As of 2024, new rese...